OBJECTIVE: GTP cyclohydrolase I (GTPCH I) catalyzes the de novo biosynthesis of tetrahydrobiopterin (BH(4)), an essential cofactor of NO-synthase. The enzyme underlies negative feedback regulation by the end product BH(4). This feedback inhibition is mediated through complex formation with the GTP cyclohydrolase I feedback regulatory protein (GFRP). To further classify the mechanism involved in the regulation of BH(4) synthesis, we measured expression of GTPCH I and GFRP in different human tissues. Furthermore, we looked for the influence of phenylalanine that is known to reverse BH(4)-mediated feedback inhibition of GTPCH I, and of immunostimulation with interferon gamma on the expression of GTPCH I and GFRP. METHODS AND RESULTS: Using RT-PCR and northern blot technique, coexpression of GFRP and GTPCH I could be demonstrated in a number of different tissues such as endothelial cells and peripheral blood cells. Following stimulation of human umbilical vein endothelial cells (HUVEC) with phenylalanine (1 mM), there was no change of GFRP mRNA. In contrast, the mRNA level of GTPCH I was significantly upregulated with a maximum after 6 hours (p = 0.04). Incubation of HUVEC with interferon-gamma (100 U/ml) showed an increase of GTPCH I mRNA and a significant downregulation of GFRP mRNA after 24 hours (p = 0.03). CONCLUSION: This study shows for the first time the expression of GFRP in different human tissues. The biosynthesis of BH(4) is not only regulated on the substrate level but also through transcription of the interacting proteins. Phenylalanine stimulates the biosynthesis of BH(4) not only by reversing the negative feedback inhibition of GTPCH I but also by increasing the mRNA level of GTPCH I. Immunostimulation alters protein expression of GTPCH I and GFRP in a way that favors BH(4) synthesis.
OBJECTIVE:GTP cyclohydrolase I (GTPCH I) catalyzes the de novo biosynthesis of tetrahydrobiopterin (BH(4)), an essential cofactor of NO-synthase. The enzyme underlies negative feedback regulation by the end product BH(4). This feedback inhibition is mediated through complex formation with the GTP cyclohydrolase I feedback regulatory protein (GFRP). To further classify the mechanism involved in the regulation of BH(4) synthesis, we measured expression of GTPCH I and GFRP in different human tissues. Furthermore, we looked for the influence of phenylalanine that is known to reverse BH(4)-mediated feedback inhibition of GTPCH I, and of immunostimulation with interferon gamma on the expression of GTPCH I and GFRP. METHODS AND RESULTS: Using RT-PCR and northern blot technique, coexpression of GFRP and GTPCH I could be demonstrated in a number of different tissues such as endothelial cells and peripheral blood cells. Following stimulation of human umbilical vein endothelial cells (HUVEC) with phenylalanine (1 mM), there was no change of GFRP mRNA. In contrast, the mRNA level of GTPCH I was significantly upregulated with a maximum after 6 hours (p = 0.04). Incubation of HUVEC with interferon-gamma (100 U/ml) showed an increase of GTPCH I mRNA and a significant downregulation of GFRP mRNA after 24 hours (p = 0.03). CONCLUSION: This study shows for the first time the expression of GFRP in different human tissues. The biosynthesis of BH(4) is not only regulated on the substrate level but also through transcription of the interacting proteins. Phenylalanine stimulates the biosynthesis of BH(4) not only by reversing the negative feedback inhibition of GTPCH I but also by increasing the mRNA level of GTPCH I. Immunostimulation alters protein expression of GTPCH I and GFRP in a way that favors BH(4) synthesis.
Authors: Philip J Lupo; Claudia Chapa; Darryl Nousome; Cody Duhon; Mark A Canfield; Gary M Shaw; Richard H Finnell; Huiping Zhu Journal: Mol Genet Metab Date: 2012-09-25 Impact factor: 4.797
Authors: Rupak Pathak; Snehalata A Pawar; Qiang Fu; Prem K Gupta; Maaike Berbée; Sarita Garg; Vijayalakshmi Sridharan; Wenze Wang; Prabath G Biju; Kimberly J Krager; Marjan Boerma; Sanchita P Ghosh; Amrita K Cheema; Howard P Hendrickson; Nukhet Aykin-Burns; Martin Hauer-Jensen Journal: Antioxid Redox Signal Date: 2013-05-03 Impact factor: 8.401
Authors: Amy L Tatham; Mark J Crabtree; Nicholas Warrick; Shijie Cai; Nicholas J Alp; Keith M Channon Journal: J Biol Chem Date: 2009-03-13 Impact factor: 5.157
Authors: Irina A Ionova; Jeannette Vásquez-Vivar; Jennifer Whitsett; Anja Herrnreiter; Meetha Medhora; Brian C Cooley; Galen M Pieper Journal: Am J Physiol Heart Circ Physiol Date: 2008-10-03 Impact factor: 4.733
Authors: Alberto Francisco Rubio-Guerra; Hilda Vargas-Robles; Luz Maria Ramos-Brizuela; Bruno Alfonso Escalante-Acosta Journal: Integr Blood Press Control Date: 2010-09-29
Authors: Pawel P Wolkow; Wladyslaw Kosiniak-Kamysz; Grzegorz Osmenda; Grzegorz Wilk; Beata Bujak-Gizycka; Adam Ignacak; Mihir Kanitkar; Malgorzata Walus-Miarka; David G Harrison; Ryszard Korbut; Maciej T Malecki; Tomasz J Guzik Journal: PLoS One Date: 2014-11-04 Impact factor: 3.240